Protective effect of DNA immunization against mycobacterial infection is associated with the early emergence of interferon-gamma (IFN-γ)-secreting lymphocytes

Clinical and Experimental Immunology

Volumn 120, Issue 3, 2000, Pages 476-482

  Kamath, A T ^a   Groat, N L ^a   Bean, A G D ^a,c   Britton, W J ^a,b  

^a CENTENARY INSTITUTE   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CSIRO   (Australia)

Author keywords

DNA vaccine; Immunity protection; Interferon gamma; Mycobacterium boris BCG

Indexed keywords

BCG VACCINE; DNA VACCINE; GAMMA INTERFERON;

ANTIGEN SPECIFICITY; ARTICLE; CELL ACTIVATION; HELPER CELL; HUMAN; HUMAN CELL; IMMUNITY; IMMUNIZATION; MEMORY CELL; MYCOBACTERIUM; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; PRIORITY JOURNAL; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; DNA; FEMALE; FLOW CYTOMETRY; INTERFERON TYPE II; MICE; MICE, INBRED C57BL; MYCOBACTERIUM BOVIS; SPLEEN; T-LYMPHOCYTE SUBSETS; TUBERCULOSIS; VACCINES, DNA;

EID: 0034124973     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2000.01240.x     Document Type: Article

References (42)

1. 1 Dye C, Sheel S, Dolan P, Pathani B, Raviglione MC. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. JAMA 1999; 282:677-86.
2. 2 Colditz GA, Brewer TF, Berkley CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta analysis of the published literature. JAMA 1994; 271:698-702.
3. 3 Sanders ME, Makgoba MW, Sharrow SO, Stephany D, Springer TA, Young HA, Shaw S. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-γ production. J Immunol 1988; 140:1401-7.
4. 4 Swain SL, Croft M, Dubey C, Haynes L, Rogers P, Zhang X, Bradley LM. From naive to memory T cells. Immunol Rev 1996; 150:143-67.
5. 5 Cerottini JC, MacDonald HR. The cellular basis of T-cell memory. Ann Rev Immunol 1989; 7:77-89.
6. 6 Ahmed R, Gray D. Immunological memory and protective immunity: understanding their relation. Science 1996; 272:54-60.
7. 7 Budd RC, Cerottini JC, Horvath C, Bron C, Pedrazzini T, Howe RC, MacDonald HR. Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. J Immunol 1987; 138:3120-9.
8. + helper T lymphocytes identified by expression of Pgp-1. J Exp Med 1989; 169:1461-6.
9. 9 Orme IM, Andersen P, Boom WH. T cell response to Mycobacterium tuberculosis. J Infect Dis 1993; 167:1481-97.
10. + T-cell subsets following infection of naive and memory immune mice with Mycobacterium tuberculosis. Infect Immun 1994; 62:1683-90.
11. 11 Andersen P, Andersen AB, Sorensen AL, Nagai S. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. J Immunol 1995; 154:3359-72.
12. 12 Huygen K, Content J, Denis O et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nature Med 1996; 2:893-8.
13. 13 Tascon RE, Colston MJ, Ragno S, Stavropoulos E, Gregory D, Lowrie DB. Vaccination against tuberculosis by DNA injection. Nature Med 1996; 2:888-92.
14. 14 Lowrie DB, Silva CL, Colston MJ, Ragno S, Tascon RE. Protection against tuberculosis by a plasmid DNA vaccine. Vaccine 1997; 15:834-8.
15. 15 Zhu X, Venkataprasad N, Thangaraj HS, Hill M, Singh M, Ivanyi J, Vordermeier HM. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. J Immunol 1997; 158:5921-6.
16. 16 Kamath AT, Feng CG, Macdonald M, Briscoe H, Britton WJ. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. Infect Immun 1999; 67:1702-7.
17. 17 Tanghe A, Lefevre P, Denis O et al. Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors. J Immunol 1999; 162:1113-9.
18. 18 Dillon DC, Alderson MR, Day CH et al. Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family. Infect Immun 1999; 67:2941-50.
19. 19 Roche PW, Peake PW, Billman-Jacobe H, Doran T, Britton WJ. T-cell determinants and antibody binding sites on the major mycobacterial secretory protein MPB59 of Mycobacterium bovis. Infect Immun 1994; 62:5319-26.
20. 20 Baumgart KW, McKenzie KR, Radford AJ, Ramshaw I, Britton WJ. Immunogenicity and protection studies with recombinant mycobacteria and vaccinia vectors coexpressing the 18-kilodalton protein of Mycobacterium leprae. Infect Immun 1996; 64:2274-81.
21. 21 Berthet FX, Lagranderie M, Gounon P et al. Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene. Science 1998; 282:759-62.
22. 22 Jackson M, Phalen SW, Lagranderie M et al. Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine. Infect Immun 1999; 67:2867-73.
23. 23 Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 1994; 62:2536-44.
24. 24 Roberts AD, Sonnenberg MG, Ordway DJ, Furney SK, Brennan PJ, Belisle JT, Orme IM. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. Immunol 1995; 85:502-8.
25. 25 Horwitz MA, Esther Lee B-W, Dillon BJ, Harth G. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1995; 92:1530-4.
26. 26 Hart PD, Sutherland I, Thomas J. The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in tuberculin skin sensitivity and to technical variations in the vaccines. Tubercule 1967; 48:201-10.
27. 27 Comstock GW, Palmer CE. Long-term results of BCG vaccination in the southern United States. Am Rev Respir Dis 1966; 93:171-83.
28. 28 Fine PEM. Immunitites in and to tuberculosis: implications for pathogenesis and vaccination. In: Porter JDH, McAdam KPWJ, eds. Tuberculosis: back to the future. Chichester: John Wiley & Son Ltd, 1993:53-74.
29. 29 Flynn J-AL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178:2249-54.
30. 30 Cooper AM, Dalton DK, Stewart TA, Griffen JP, Russell JP, Orme IM. Disseminated tuberculosis in interferon γ gene-disrupted mice. J Exp Med 1993; 178:2243-7.
31. +, T cells in lungs following aerosol infection with Mycobacterium tuberculosis. Infect Immun 1999; 67:3242-7.
32. + T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells. J Exp Med 1998; 187:1633-40.
33. + T cells requires the production of gamma interferon. Infect Immun 1998; 66:830-4.
34. 34 Follows GA, Munk ME, Gatrill AJ, Conradt P, Kaufmann SHE. Gamma interferon and interleukin 2, but not interleukin 4 are detectable in γδ T-cell cultures after activation with bacteria. Infect Immun 1992; 60:1229-31.
35. 35 Ladel CH, Blum C, Dreher A, Reifenberg K, Kaufmann SHE. Protective role of γδ T cells and αβ T cells in tuberculosis. Eur J Immun 1995; 25:2877-81.
36. 36 Launois P, deLeys R, Niang MN et al. T-cell epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy. Infect Immun 1994; 62:3679-87.
37. 37 Roach DR, Briscoe H, Rathjen DA, Britton WJ. Tumour necrosis factor and a TNF against neptide modulates the granulomatous response to mycobacterial infection in mice. Infect Immun 1999; 23:1-2.
38. 38 Cooper AM, Callahan JE, Keen M, Belisle JT, Orme IM. Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis. Tubercle Lung Dis 1997; 78:67-73.
39. + T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nature Med 1998; 4:397-402.
40. 40 Hanke T, Blanchard TJ, Schneider J et al. Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. Vaccine 1998; 16:439-45.
41. 41 Mohagheghpour N, Gammon D, Kawamura LM, van Vollenhoven A, Benike CJ, Engleman EG. CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. J Immunol 1998; 161:2400-6.
42. + T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1998; 95:270-5.